Shares of Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) rose 0.4% during mid-day trading on Thursday . The company traded as high as $44.07 and last traded at $44.07. 100 shares were traded during mid-day trading, a decline of 93% from the average daily volume of 1,353 shares. The stock had previously closed at $43.88.
Hikma Pharmaceuticals Price Performance
The company’s 50 day simple moving average is $42.95 and its 200 day simple moving average is $39.52.
Hikma Pharmaceuticals Company Profile
Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.
The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.
Recommended Stories
- Five stocks we like better than Hikma Pharmaceuticals
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
- Amazon’s Zoox Push Tests Tesla’s Robotaxi Premium as Waymo Widens Its Lead
- MarketBeat Week in Review – 08/24 – 08/28
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
